Denglong Wu

4PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 10, 2024
PRL-mediated STAT5B/ARRB2 pathway promotes the progression of prostate cancer through the activation of MAPK signaling.

Tao Yang, Yongnan Chi, Xin'an Wang

|Oct 24, 2023
Nucleophosmin 1 cooperates with BRD4 to facilitate c-Myc transcription to promote prostate cancer progression.

Zhe Hong, Chengdang Xu, Shengfeng Zheng

|Mar 24, 2022
Histone methyltransferase KMT2C plays an oncogenic role in prostate cancer.

Jianpo Lian, Chengdang Xu, Xi Chen

|Mar 23, 2022
High-dose-androgen-induced autophagic cell death to suppress the Enzalutamide-resistant prostate cancer growth via altering the circRNA-BCL2/miRNA-198/AMBRA1 signaling.

Lei Chen, Yin Sun, Min Tang

Pageof 1

Frequent Collaborators

1 joint publications

Chawnshang Chang

1 joint publications

Tao Yang

1 joint publications

Xi Chen

1 joint publications

Shengsong Huang